Clinical trials
Parkinson Disease, Idiopathic clinical trials
Below are recruiting parkinson disease, idiopathic clinical trials, each written for real people, not researchers. We’re tracking 209 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06733077Recruiting
Digital services for Parkinson's disease
This study is developing digital services for people with Parkinson's disease and also includes healthy volunteers. It aims to understand movement problems like freezing of gait and festination, and uses a virtual reality system to measure these issues.
ExeterAges 18 years+ - NCT07213219Recruiting
PET-MRI scan for Parkinson's with sleep behavior disorder
This trial uses a combined PET and MRI scan to study the brain's reward system in people with Parkinson's disease who also have REM sleep behavior disorder (RBD). It aims to understand how the brain changes and may help guide future treatments.
Clermont-FerrandAges 45–80 - NCT07142044RecruitingPhase 1/Phase 2
Testing EC5026 for Parkinson's disease
This study tests a new oral medication called EC5026 for Parkinson's disease. It aims to see if the drug is safe and if it might help control symptoms when added to your current levodopa treatment.
Sacramento, CaliforniaAges 50–80 - NCT06899022Recruiting
Attention and eye movement in Parkinson's disease
This study looks at how attention and eye movements work in people with Parkinson's disease, essential tremor, or dystonia. It tests abilities during deep brain stimulation (DBS) surgery and when DBS settings are changed.
Omaha, NebraskaAges 19–90 - NCT05070013Recruiting
Brain stimulation to improve sleep in people with Parkinson’s disease
This study tests an adaptive brain stimulation device to help restore better sleep in people with Parkinson’s disease. You may be eligible if your Parkinson’s motor symptoms are severe despite best medical treatment and you are already being considered for a specific deep brain stimulation surgery.
Omaha, NebraskaAges 18–80 - NCT05769699Recruiting
Blood test study for Parkinson’s stages
This study measures blood biomarkers (measurable substances in blood) in people with Parkinson’s at different stages. It may help doctors understand how Parkinson’s changes over time and could guide future testing or treatments.
RomaAges 18–80 - NCT07787299Recruiting
Wearable sensors for monitoring tremor in Parkinson's disease
This study tests whether wearable sensors can accurately measure tremor and other movement symptoms in people with Parkinson's disease or essential tremor. Participating may help improve how doctors monitor symptoms at home.
Edinburgh, EdinburghAges 18 years+ - NCT07679256Recruiting
Digital and brain markers for early Parkinson's diagnosis
This study uses digital tools and brain markers to detect Parkinson's disease early. It includes healthy people, those with early Parkinson's, and those with REM sleep behavior disorder (a possible early sign).
Fuzhou, FujianAges 40–80 - NCT07376278Recruiting
Deep brain stimulation outcomes in Parkinson's disease
This study looks at factors that predict how well deep brain stimulation (DBS) works for people with Parkinson's disease. If you are considering DBS, joining this research could help doctors better understand who benefits most from the procedure.
Hong KongAges 18–75 - NCT06909045Recruiting
Adaptive vs. regular deep brain stimulation for Parkinson's
This study compares two ways of using deep brain stimulation (DBS) — an adjustable ‘adaptive’ version that changes with your brain signals, versus the standard continuous setting. It aims to see which works better for people with Parkinson's disease who already have a specific type of DBS device.
LeuvenAges 18 years+ - NCT06588920Recruiting
Brain activity, thinking, and walking study for Parkinson's
This study looks at how brain activity relates to thinking and walking in people with Parkinson's disease. It may help understand the connections between these functions.
TaipeiAges 40–80 - NCT05658302Recruiting
Deep brain stimulation for Parkinson’s, using targeted stimulation
This study is testing a specific approach to deep brain stimulation (DBS) for people with Parkinson’s disease who are getting DBS surgery as part of routine care. It may help doctors learn whether circuit-based, more targeted stimulation is safe and useful for Parkinson’s symptoms.
Minneapolis, MinnesotaAges 21 years+ - NCT07380737Recruiting
Walking Tall app for home exercise in Parkinson's
This study tests a smartphone app called Walking Tall that helps people with Parkinson's disease do walking exercises at home. It's looking for people who can walk on their own and are already in a specific rehab program.
Tel AvivAges 40–85 - NCT06916507Recruiting
Early treatment with a new Parkinson's drug
This study tests a new form of Parkinson's medication given through a pump to see how well it works in everyday life for people in the early stages of advanced Parkinson's. It may help control symptoms and improve daily function.
Allensbach, Baden-WurttembergAges 18–67 - NCT05752656Recruiting
Tracking outcomes after deep brain stimulation for Parkinson’s
This study follows people with Parkinson’s disease to see how their thinking, behavior, and movement change over time after deep brain stimulation. It may help doctors better understand what to expect from this treatment.
RomeAges 18 years+ - NCT05182892Recruiting
Reducing speech side effects from DBS using speech recordings
This study tests whether automated analysis of your speech can help reduce speech problems caused by deep brain stimulation (DBS) in Parkinson’s disease. It may help your team adjust DBS settings to improve how you speak while keeping Parkinson symptoms controlled.
PragueAges 18 years+ - NCT04888364Recruiting
French study following people with Parkinson’s and related conditions
This study follows people with Parkinson’s disease, certain Parkinson-like conditions, and some people at higher risk. It helps researchers learn how these illnesses start and progress, which may lead to better earlier detection and care.
ParisAges 10 years+ - NCT06815302Recruiting
Improving turning and freezing in Parkinson's disease
This study tests whether a 6-week exercise program can help people with Parkinson's disease who experience freezing of gait. You would exercise three times a week to see if it reduces freezing and improves turning.
Tempe, ArizonaAges 50–80 - NCT06821230Recruiting
Mindfulness for Parkinson's patients and their caregivers
This study tests whether a dyadic mindfulness program can help both people with Parkinson's disease and their caregivers manage negative emotions. You and your care partner would attend sessions together to learn mindfulness techniques.
Hong KongAges 18 years+ - NCT07284342Recruiting
Study on sleep and advanced Parkinson's with foslevodopa/foscarbidopa
This study looks at how a Parkinson's drug delivered under the skin (foslevodopa/foscarbidopa) affects sleep problems in people with advanced Parkinson's. It is a real-world study that follows your usual treatment, no new experimental drug is being tested.
Málaga, AndalusiaAges 18 years+ - NCT07253376Enrolling by invitation
Study of a cognitive function scale for Parkinson's in Turkish
This study is testing a new rating scale (a set of questions) to measure how well people with Parkinson's disease can handle daily tasks that require thinking skills. It aims to make sure the scale works well in Turkish.
AnkaraAges 40 years+ - NCT05626608Recruiting
Directional brain stimulation for Parkinson’s tremor and movement control
This trial tests a continuous electrical brain stimulation device placed in a deep brain area to help Parkinson’s symptoms—especially tremor and trouble with movement. It may help improve daily function and reduce periods when medicine does not work well.
Montpellier, FranceAges 18–70 - NCT05818189Recruiting
Study walking brain signals in Parkinson’s with medication and cues
This study measures brain activity while you walk using a noninvasive light sensor setup. Researchers want to see how Parkinson’s medication and simple “walking cues” change balance and brain signals.
Portland, OregonAges 45–85 - NCT07804615RecruitingPhase 2
Investigational drug for tremor from Parkinson's disease
This study is testing an investigational drug for Parkinson's-related tremor (shaking). It aims to see if the drug can help reduce tremor in people whose symptoms are not fully controlled by current treatment.
Scottsdale, ArizonaAges 18–65
Hear when a new Parkinson Disease, Idiopathic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for parkinson disease, idiopathic?
- Yes. Clin2 currently lists 209 recruiting parkinson disease, idiopathic studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a parkinson disease, idiopathic trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a parkinson disease, idiopathic trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.